MARKET

TLGTQ

TLGTQ

Teligent
EXMKT

Real-time Quotes | Nasdaq Last Sale

0.0001
0.0000
0.00%
Closed 16:00 05/18 EDT
OPEN
--
PREV CLOSE
0.0001
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.658
52 WEEK LOW
0.0001
MARKET CAP
9.28K
P/E (TTM)
-0.0000
1D
5D
1M
3M
1Y
5Y
Generic drugmaker Teligent approved to tap bankruptcy loan
Teligent Inc on Friday secured court approval to access part of a $12 million loan to fund operations while the generic drugmaker works through its bankruptcy and sale process.
Reuters · 10/15/2021 19:58
22 Stocks Moving in Friday's Pre-Market Session
Gainers
Benzinga · 10/15/2021 11:03
Generic drugmaker Teligent files for Chapter 11, plans sale
Generic drugmaker Teligent Inc filed for bankruptcy protection on Thursday with plans to sell itself, citing "regulatory and legal setbacks" including a warning letter from the U.S. Food and Drug Administration related to its manufacturing processes.
Reuters · 10/14/2021 19:48
Generic drug maker Teligent files for bankruptcy protection, explores sale of the company
South Jersey specialty generic pharmaceutical firm Teligent Inc. filed for voluntarily bankruptcy protection on Thursday as it pursues the sale of the company or its core assets. Teligent Inc. of Buena in Atlantic County also said it is arranging for $12 ...
American City Business Journals · 10/14/2021 12:57
The Daily Biotech Pulse: Moderna Awaits Adcom Ruling On COVID-19 Booster Shot; Teligent Files For Chapter 11; CFO Transitions at Catalyst Biosciences, CRISPR; Lucid Diagnostics Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours:
Benzinga · 10/14/2021 12:07
Teligent To Pursue Asset Sale Through Voluntary Chapter 11 Process
Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company ("Teligent" or the "Company"), today announced that the Company has, together with certain of its
Benzinga · 10/14/2021 10:16
Teligent Pharma Issued Voluntary Recall Of Lidocaine Topical Solution 4%, Cites 'Super Potency'
-Reuters
Reuters · 08/30/2021 16:43
BRIEF-FDA Says Teligent Pharma, Inc.’S Issues Voluntary Recall Of Lidocaine Hcl Topical Solution 4% (Lot # 14218, Exp. 09/2022) Due To Super Potency
reuters.com · 08/30/2021 16:42
More
No Data
Learn about the latest financial forecast of TLGTQ. Analyze the recent business situations of Teligent through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
0.00%Buy
100.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average TLGTQ stock price target is 1.000 with a high estimate of 1.000 and a low estimate of 1.000.
High1.000
Average1.000
Low1.000
Current 0.0001
EPS
Actual
Estimate
-3.96-2.96-1.96-0.96
Q3 2020
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Institutional Holdings
Institutions: 73
Institutional Holdings: 25.09M
% Owned: 27.03%
Shares Outstanding: 92.82M
TypeInstitutionsShares
Increased
6
1.54M
New
7
524.88K
Decreased
7
2.36M
Sold Out
8
183.70K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
-1.80%
Pharmaceuticals & Medical Research
-2.06%
Key Executives
Non-Executive Chairman/Independent Director
John Celentano
Chief Financial Officer
Alyssa Lozynski
Other
Vladimir Kasparov
Director
Bradley Scher
Independent Director
Carole Ben-Maimon
Independent Director
Thomas Sabatino
No Data
No Data
About TLGTQ
Teligent, Inc. is a generic pharmaceutical company. The Company is focused on the development, manufacturing and marketing of a portfolio of generic pharmaceutical products under its own label and private label for other pharmaceutical companies in topical, injectable, complex and other dosage forms. It also provides contract development and manufacturing services to the prescription and over-the-counter (OTC) pharmaceutical and cosmetic markets. Under the Company's own label, it markets and sells generic topical, and generic and branded generic injectable pharmaceutical products in the United States and Canada. In the United States, the Company markets approximately 37 generic topical pharmaceutical products and one branded injectable pharmaceutical product. In Canada, it markets approximately 24 generic injectable, one generic topical and three generic ophthalmic products.

Webull offers kinds of Teligent Inc (NEW JERSEY) stock information, including EXMKT:TLGTQ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TLGTQ stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TLGTQ stock methods without spending real money on the virtual paper trading platform.